Methods of treating inflammation

An isolated peptide, its pharmacologically acceptable salts, derivatives, and conjugates,

• characterized in that the peptide has an amino acid sequence SEQ ID NO:
• 1, as indicated below:
• (SEQ ID NO:
• 1)
• C-X1-X2-YFYTS-X3-X4-X5-X6-X7-X8-X9-X10-X11-X12-X13-X14-X15-C
• where:
• X1 is chosen from the group containing lysine, glutamine, arginine, histidine and asparagine, or an amino acid deletion;
• X2 is chosen from the group containing glutamic acid, aspartic acid and glutamine, or an amino acid deletion;
• X3 is chosen from the group containing glycine, serine and alanine;
• X4 is chosen from the group containing lysine, leucine and arginine;
• X5 is chosen from the group containing serine, cysteine, glycine and threonine;
• X6 is chosen from the group containing proline and alanine;
• X7 is chosen from the group containing asparagine and glutamine;
• X8 is chosen from the group containing proline, tyrosine and glycine;
• X9 is chosen from the group containing glycine, alanine and serine;
• X10 is chosen from the group containing isoleucine, valine and asparagine;
• X11 is chosen from the group containing valine, isoleucine and asparagine;
• X12 is chosen from the group containing phenylalanine, tyrosine, isoleucine, valine, leucine and methionine;
• X13 is chosen from the group containing isoleucine, valine, leucine, methionine and phenylalanine;
• X14 is chosen from the group containing threonine, glycine, alanine, serine and tyrosine;
• X15 is chosen from the group containing arginine, lysine, alanine, glutamine, histidine and asparagine, or an amino acid deletion.